The present study was performed on primary cultures and subcultures of cerebellar astrocytes in order to investigate the effects of transforming growth factor-beta 1 (TGF beta 1) on proliferation, extracellular matrix (ECM) components, and cytoskeletal structures in relation to morphological changes. The expression and cellular distribution of the ECM components laminin and fibronectin and the cytoskeletal proteins glial fibrillary acidic protein (GFAP) and actin were investigated by immunoblotting, immunocytochemistry, and phalloidin staining. The proliferation of primary cultures was strongly inhibited by TGF beta 1. Treated cells became enlarged and spread onto the substratum. TGF beta 1 promoted the appearance of actin stress fibers and increased the cell actin content. It elicited a slight increase in GFAP expression and induced dispersion of thin filaments of GFAP. TGF beta 1 also stimulated the production of laminin and fibronectin and their incorporation into the ECM of primary cultures grown in medium with or without serum. Astrocytes grown in serum-containing medium for 1 day after subculturing responded strongly to TGF beta 1. Changes promoted by TGF beta 1 in cell shape, cytoskeleton, and ECM production of cultured astrocytes may have relevance for understanding the mechanisms of action of TGF beta 1 during brain development.
The iodothyronine deiodinases are a family of selenoproteins that metabolize thyroxine and other thyroid hormones to active and inactive metabolites in a number of tissues including brain. Using primary cultures of rat astroglial cells as a model system, we demonstrate that the mRNA for the type II iodothyronine deiodinase (DII) selenoenzyme is rapidly and markedly induced by forskolin and 8-bromo-cAMP. The induction of DII activity, however, was significantly impaired by culturing cells in selenium-deficient medium for 7 days. Under such conditions, the addition of selenium resulted in a rapid increase in cAMP-induced DII activity that was dose-dependent, with maximal effects noted within 2 h. Cycloheximide blocked this effect of selenium on restoring cAMP-induced DII activity, whereas actinomycin D did not. These data demonstrate that the DII selenoenzyme is expressed in cultured astrocytes and that the induction of DII activity by cAMP analogues appears to be mediated, at least in part, by pretranslational mechanisms. Furthermore, selenium deprivation impairs the expression of DII activity at the level of translation.Recent molecular cloning studies have identified cDNAs that code for a family of structurally related iodothyronine deiodinases (1-4). These oxidoreductases catalyze the removal of iodide from the phenolic (5Ј-position) or the tyrosyl (5-position) ring of thyroxine (T 4 ) 1 to form the active compound 3,5,3Ј-triiodothyronine (T 3 ) or the inactive metabolite 3,3Ј,5Ј-triiodothyronine, respectively (5). Based on both their unique functional properties and the structural information derived from cDNA sequences, three isoforms designated type I, II, and III iodothyronine deiodinases (DI, DII, and DIII, respectively) have been identified.The cDNAs for all three deiodinase isoforms contain within their coding regions an in-frame TGA triplet that has been demonstrated to code for the uncommon amino acid selenocysteine (1, 2, 4, 6, 7). This residue plays an essential role in the function of these enzymes; mutagenesis of the TGA triplet to a cysteine codon markedly reduces catalytic activity (1-3). It thus appears that the more potent nucleophilic capability of selenium, as compared with sulfur, is required for efficient deiodination. This thesis has been underscored by the identification of cDNAs coding for homologues of these enzymes from several fish, amphibian, and mammalian species (3, 8 -10). All such cDNAs isolated to date have demonstrated strict conservation of the active-site selenocysteine codon.Complementary DNAs that code for DII from Rana catesbeiana (3), rat (designated rBAT1-1), and human have been identified most recently (4). The proteins coded by these cDNAs are highly conserved; rBAT1-1 DII demonstrates 73 and 87% amino acid identity to the R. catesbeiana and human homologues, respectively. In addition, expression studies have demonstrated that these enzymes manifest all of the unique characteristics of DII (3, 4, 7).Evidence that the rBAT1-1 DII cDNA and its human and amphibian homo...
The effects of transforming growth factor beta 1 (TGF beta 1) on DNA synthesis and functional differentiation of astroglial cells cultured in serum-free medium were investigated. TGF beta 1 diminished and delayed the peak of DNA synthesis induced by serum. TGF beta 1-treated cells were larger than control cells. This factor delayed the appearance of process-bearing cells induced by acidic fibroblast growth factor treatment and also affected the astrocyte-specific enzyme glutamine synthetase (GS), whose accumulation is under hydrocortisone (HC) control. TGF beta 1 inhibited the induction of GS activity by HC in a dose- and time-dependent manner. Moreover, pretreatment with TGF beta 1 for 4 h maintained the inhibition of GS activity for approximately 16 h after removal of this factor from culture medium. These results suggest that TGF beta 1 may be an important regulator of astrocyte growth and differentiation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.